World leader in antibacterial & antiviral drug research and development
News
Venatorx Pharmaceuticals Awarded up to $44.2 Million to Advance Novel Inhibitors of Penicillin Binding Proteins targeting WHO Critical Priority Pathogen
July 27, 2020
Venatorx Pharmaceuticals Named ‘Best Places to Work’ Third Year in a Row
June 30, 2020
>> More News
Upcoming Events
IDWeek 2020
Wednesday, October 21, 2020 - Sunday, October 25, 2020 (Virtual)
BARDA Industry Day 2020
Tuesday, October 27, 2020 (Virtual)
>> More Events
Pipeline
You are using a browser that is not supported. Please consider changing your browser